NICOLE NUNEZ: Open Payments
NPI 1528559796 · ALBUQUERQUE, NM. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$349 in 18 payments from 9 companies in 2025. Trend: 2023 $65 · 2024 $240 · 2025 $349
Food & beverage: $349
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 5 | $95 |
| Lundbeck LLC | 3 | $59 |
| SANOFI PASTEUR INC. | 2 | $49 |
| Lilly USA, LLC | 3 | $47 |
| PFIZER INC. | 1 | $24 |
| Astellas Pharma US Inc | 1 | $23 |
| Neurocrine BioSciences, Inc. | 1 | $23 |
| AstraZeneca Pharmaceuticals LP | 1 | $15 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $14 |
Products named: REXULTI, Wegovy, MOUNJARO, Ozempic, FLUBLOK QUADRIVALENT NORTHERN HEMISPHERE, PREVNAR 20, Veozah, BEYFORTUS.
Industry payments across NM — which companies pay providers there.
